Christine Copeman is a senior principal scientific advisor with over 30 years of experience in safety assessment, involved in development programs for pharmaceutical and biotechnology products with particular expertise in the areas of systemic toxicology and CNS targeted deliveries. Christine is experienced in designing, overseeing, and managing non-clinical safety assessment programs for a range of modalities including small molecules, biologics, oligonucleotides, siRNAs, and gene therapies for a broad array of therapeutic indications, including orphan indications.
Christine Copeman, BSc
Dip Ecotox, Senior Principal Scientific Advisor